KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Gains from Investment Securities (2016 - 2023)

Historic Gains from Investment Securities for Alto Ingredients (ALTO) over the last 13 years, with Q4 2023 value amounting to -$7.5 million.

  • Alto Ingredients' Gains from Investment Securities rose 2673.84% to -$7.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$324000.0, marking a year-over-year increase of 8567.64%. This contributed to the annual value of $627000.0 for FY2024, which is 29351.85% up from last year.
  • Alto Ingredients' Gains from Investment Securities amounted to -$7.5 million in Q4 2023, which was up 2673.84% from $7.7 million recorded in Q3 2023.
  • Alto Ingredients' Gains from Investment Securities' 5-year high stood at $7.7 million during Q3 2023, with a 5-year trough of -$10.2 million in Q4 2022.
  • For the 5-year period, Alto Ingredients' Gains from Investment Securities averaged around -$508090.9, with its median value being $207000.0 (2020).
  • Per our database at Business Quant, Alto Ingredients' Gains from Investment Securities plummeted by 464685.99% in 2021 and then surged by 5628.91% in 2023.
  • Alto Ingredients' Gains from Investment Securities (Quarter) stood at $229000.0 in 2019, then dropped by 9.61% to $207000.0 in 2020, then tumbled by 4646.86% to -$9.4 million in 2021, then dropped by 8.64% to -$10.2 million in 2022, then grew by 26.74% to -$7.5 million in 2023.
  • Its Gains from Investment Securities was -$7.5 million in Q4 2023, compared to $7.7 million in Q3 2023 and -$574000.0 in Q1 2023.